Published papers
Academic conference presentation
    （Last updated : 2024-01-29 14:35:35）
  池田　敬至
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Research Associate
■ Published papers
1. Original article　 Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. 2024/01
2. Original article　 Comparison of outcomes between therapeutic combinations based on immune checkpoint inhibitors or tyrosine kinase inhibitor monotherapy for first-line therapy of patients with advanced renal cell carcinoma outside of clinical trials: A real-world retrospective multi-institutional study. 2023/03
3. Original article　 Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. 2021/10
4. Original article　 Prognostic impact of early treatment interruption of nivolumab plus ipilimumab due to immune-related adverse events as first-line therapy for metastatic renal cell carcinoma: A multi-institution retrospective study. 2021/07
5. Original article　 Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end‐stage renal disease. 2020/11
Display all(8)
■ Academic conference presentation
1. A novel method for ex vivo stimulation of mesenchymal stem cells via invariant natural killer T cell activation with ɑ-galactosylceramide.  2022/06/05
2. Predictive factors related to the number of TUL for kidney stones in our hospital.  2020/12/22
3. Genetic and epigenetic profiling reveals the proximal tubule origin of renal cancers in end-stage renal disease.  2020/10/01
4. Long-term follow-up of renal function and development of chronic kidney disease after partial nephrectomy.  2019/05/04
5. Usefulness of the modified Glasgow Prognostic Score (mGPS) in patients with castration- sensitive prostate cancer: muti- institutional study.  2018/04/19
Display all(7)